Pages that link to "Q33933911"
Jump to navigation
Jump to search
The following pages link to Molecular mechanisms of tumor-bone interactions in osteolytic metastases (Q33933911):
Displaying 50 items.
- Interfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression (Q24793548) (← links)
- Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy (Q26745444) (← links)
- Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma (Q26771376) (← links)
- Cytokines as Mediators of Pain-Related Process in Breast Cancer (Q26774863) (← links)
- High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms (Q26777956) (← links)
- The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis (Q27437809) (← links)
- Calcium-Sensing Receptor in Breast Physiology and Cancer (Q28071486) (← links)
- A novel 3-D mineralized tumor model to study breast cancer bone metastasis (Q28472598) (← links)
- Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells (Q33416408) (← links)
- PTHrP gene expression in cancer: do all paths lead to Ets? (Q33705984) (← links)
- Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. (Q33819359) (← links)
- Tumor-supportive and Osteoclastogenic Changes Induced by Breast Cancer-derived Factors Are Reversed by Inhibition of γ-Secretase (Q34181380) (← links)
- Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma (Q34267831) (← links)
- SDF-1 inhibition targets the bone marrow niche for cancer therapy (Q34324830) (← links)
- Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126. (Q34365784) (← links)
- Animal models of bone metastasis (Q34675085) (← links)
- Enpp1: a potential facilitator of breast cancer bone metastasis (Q34825300) (← links)
- Kinetics of metastatic breast cancer cell trafficking in bone. (Q34871669) (← links)
- Breast cancer at bone metastatic sites: recent discoveries and treatment targets. (Q34939979) (← links)
- WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone (Q34971961) (← links)
- Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? (Q35083485) (← links)
- Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. (Q35954707) (← links)
- Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases (Q35987375) (← links)
- Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. (Q36072569) (← links)
- Myeloma as a model for the process of metastasis: implications for therapy (Q36079800) (← links)
- Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL (Q36491545) (← links)
- A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to bone (Q36519704) (← links)
- Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis. (Q36737426) (← links)
- L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer (Q36853886) (← links)
- Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma. (Q37117104) (← links)
- Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation (Q37246530) (← links)
- Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis. (Q37249049) (← links)
- Multimodality imaging of TGFbeta signaling in breast cancer metastases (Q37280775) (← links)
- Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis (Q37350475) (← links)
- Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer (Q37575983) (← links)
- Hypercalcaemia and hypocalcaemia: finding the balance (Q37736066) (← links)
- Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients (Q38648494) (← links)
- Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity (Q38703517) (← links)
- MicroRNA Exert Macro Effects on Cancer Bone Metastasis (Q38910342) (← links)
- Wild-type and specific mutant androgen receptor mediates transcription via 17β-estradiol in sex hormone-sensitive cancer cells. (Q38925848) (← links)
- The role of extracellular calcium in bone metastasis (Q38985689) (← links)
- Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases (Q39884416) (← links)
- Osteolysis and cancer (Q39946675) (← links)
- A murine model of bone marrow micrometastasis in breast cancer (Q40681532) (← links)
- Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model (Q41497465) (← links)
- Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma (Q41712371) (← links)
- Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases (Q43011355) (← links)
- Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course. (Q44368912) (← links)
- Bisphosphonates for malignant bone tumors (Q46083954) (← links)
- Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis (Q47171640) (← links)